- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06258369
Gait Initiation and Transition From Double to Single Support in Patients With Unilateral Primary Coxarthrosis (COXAM)
Gait Initiation and Transition From Double to Single Support in Patients With Unilateral Primary Coxarthrosis Who Have Not Undergone Surgery and Before/After Arthroplasty
The study consists to evaluate the impact of prosthetic surgery (PTH and RTH) on kinematic and dynamic parameters (joint torques) of the lower limbs during gait initiation in patients with primary coxarthrosis.
Patients included in the study will undergo a three-dimensional gait analysis. Dynamic gait analysis is multidimensional, measuring kinematic parameters (joint amplitudes: ankles, knees, hips, etc.) and dynamic parameters (assessment of joint torque from ankle, knee, hip to lower limb during gait initiation).
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Marie-Paule LEBITASY
- Phone Number: +33 3 20 22 52 69
- Email: urm@ghicl.net
Study Contact Backup
- Name: William's VAN DEN BERGHE
- Phone Number: +33 3 20 22 57 31
- Email: VanDenBerghe.Williams@ghicl.net
Study Locations
-
-
-
Lille, France, 59000
- Not yet recruiting
- CHU de LILLE
-
Contact:
- Julien GIRARD
- Email: Julien.GIRARD@chu-lille.fr
-
Principal Investigator:
- Julien GIRARD
-
Lomme, France, 59462
- Recruiting
- Hôpital Saint-Philibert (GHICL)
-
Contact:
- Pierre MARTINOT, MD
- Email: Martinot.Pierre@ghicl.net
-
Principal Investigator:
- Pierre MARTINOT, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Men or women aged 18 and over
- With primary coxarthrosis (any stage)
- Consulting in the orthopedic departments of participating centers in anticipation of hip surgery (PTH/RTH), or for advice only.
- Written consent signed by the patient
- Affiliation with a social security scheme
Exclusion Criteria:
- Disabling orthopaedic conditions:
Symptomatic contralateral hip/knee disease Symptomatic gonarthrosis or homolateral total knee prosthesis History of surgery on the affected hip History of fracture of the lower limb in the past year History of lower limb sprain in the last 3 months Neurological or degenerative disease
- Pregnant or breast-feeding
- Adults under guardianship, curatorship or safeguard of justice
- Cognitive impairment making it impossible to understand the protocol
- Approach other than Moore posterolateral (for PTH and RTH groups)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Patients with primary coxarthrosis (any stage).
|
Patients who do not undergo surgery will be called specifically for the study to attend a consultation dedicated to gait assessment.
|
|
Experimental: Patients with primary coxarthrosis (any stage) and operated with Total Hip prosthesis (THP).
|
Patients scheduled for THP (Total Hip Prosthesis) will be seen at the consultation the day before surgery, in the same hospital as the THP, or at an existing dedicated consultation scheduled for all THP patients.
During these scheduled visits, they will be received in the gait analysis laboratory for a gait assessment (V1).
Patients will be seen again at 6 months post-operatively for a second gait assessment (V2).
|
|
Experimental: Patients with primary coxarthrosis (any stage) and operated with RTH (Hip resurfacing).
|
Patients scheduled for RTH (Hip Resurfacing) will be seen at the consultation the day before surgery, in the same hospital as the RTH, or at an existing dedicated consultation scheduled for all RTH patients.
During these scheduled visits, they will be received in the gait analysis laboratory for a gait assessment (V1).
Patients will be seen again at 6 months post-operatively for a second gait assessment (V2).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Amplitude degree of lower limbs articulations
Time Frame: 6 months
|
6 months
|
|
Dynamics of limbs joint torques during walking initiation measured in Nm/kg
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Step length during gait initiation
Time Frame: 6 months
|
6 months
|
|
|
Step width during gait initiation
Time Frame: 6 months
|
6 months
|
|
|
Duration of first step during gait initiation
Time Frame: 6 months
|
6 months
|
|
|
Duration of anticipatory postural adjustment phase during gait initiation
Time Frame: 6 months
|
6 months
|
|
|
Duration of execution phase during gait initiation
Time Frame: 6 months
|
6 months
|
|
|
Measurement of the trajectory during gait initiation
Time Frame: 6 months
|
6 months
|
|
|
Measurement of the speed during gait initiation
Time Frame: 6 months
|
6 months
|
|
|
Measurement of the amplitude of retreat of the center of pressure during gait initiation
Time Frame: 6 months
|
6 months
|
|
|
Severity of coxarthrosis according to the Tönnis classification
Time Frame: 6 Months
|
The severity of coxarthrosis is assessed on radiographs according to the Tönnis classification: Grade Radiographic features 0 - No signs of osteoarthritis
|
6 Months
|
|
HHS (Harris Hip Score)
Time Frame: 6 months
|
The functional score consists of 10 items out of 100 points (best score = 100 points) assessing function, pain and mobility
|
6 months
|
|
PMA (Postel Merle d'Aubigné) score
Time Frame: 6 months
|
Score on 3 items (pain, mobility and walking) rated on 18 points (18 = excellent results, 0 = worst result)
|
6 months
|
|
Devane score
Time Frame: 6 months
|
Activity score with 5 possibilities (1 = sedentary work and 5 = power work, competitive sport)
|
6 months
|
|
UCLA (University of California Los Angeles) score
Time Frame: 6 months
|
Activity score comprising 10 possibilities and assessing the intensity of physical activity (1= inactive or dependent patient, 10 = regular practice of high-impact sports)
|
6 months
|
|
Vellas unipodal weight-bearing test
Time Frame: 6 months
|
This test consists in asking the patient to balance for as long as possible.
A time of more than 30 seconds indicated a very low risk of falls.
A time of less than 5 seconds indicates a very high risk of falls.
|
6 months
|
|
Pelvic incidence
Time Frame: 6 months
|
Pelvic incidence is a constant morphologic parameter that describes the "pelvic size" based on the angular relation between femoral heads and sacral plate for any given person
|
6 months
|
|
Sacral slope angle
Time Frame: 6 months
|
Spatial orientation of the pelvis in the sagittal plane is assessed by the sacral slope
|
6 months
|
|
Pelvic tilt angle
Time Frame: 6 months
|
Pelvic tilt is a position-dependent parameter defined as the angle created by a line running from the sacral endplate midpoint to the center of the bifemoral heads and the vertical axis.
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Pierre MARTINOT, MD, Hôpital Saint Philibert, GHICL
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC-P00122
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary; Coxarthrosis
-
University Hospital, BrestRecruitingCoxarthrosis; Primary | Coxarthrosis; SecondaryFrance
-
Hacettepe UniversityCompleted
-
Istituto Ortopedico RizzoliWithdrawnCoxarthrosis; PrimaryItaly
-
Aesculap AGRecruitingCoxarthrosis; PrimaryCzechia
-
Ankara City Hospital BilkentCompletedCoxarthrosis; PrimaryTurkey
-
Smith & Nephew Orthopaedics AGCompletedPrimary and Secondary Coxarthrosis | Dysplasia Coxarthrosis | Post-traumatic Necrosis of the Femoral HeadGermany
-
Societe ACTIVBIOMATSlb PharmaActive, not recruitingOsteoarthritis, Hip | Hip Arthroplasty Replacement | Hip Arthroplasty | Osteonecrosis; Aseptic, Idiopathic | Coxarthrosis; Primary | Coxarthrosis; Secondary | Hip Arthroplasty, TotalFrance
-
Aesculap AGActive, not recruitingRheumatoid Arthritis | Hip Dysplasia | Fractures, Hip | Necrosis, Femur Head | Coxarthrosis; Primary | Coxarthrosis; Post-TraumaticGermany
-
Technical University of MunichRecruiting
-
TRB Chemedica AGCompleted
Clinical Trials on Patients with primary coxarthrosis (any stage).
-
Institut Claudius RegaudCompleted
-
Alexandria UniversityCompleted
-
University of AarhusCompletedComplications After Bariatric SurgeryDenmark
-
Terumo Europe N.V.CompletedAcute ST Segment Elevation Myocardial InfarctionBrazil, Serbia, Italy, Spain, Macedonia, The Former Yugoslav Republic of
-
Namik Kemal UniversityCompletedEnd Stage Renal DiseaseTurkey
-
University of AarhusUnknown
-
Grupo Argentino de Tratamiento de la Leucemia AgudaRecruitingLymphoma, Non-Hodgkin's, AdultArgentina
-
Fundacio d'Investigacio en Atencio Primaria Jordi...CompletedType 2 Diabetes | Cardiovascular Risk Factor | GenderSpain
-
Kansas City Heart Rhythm Research FoundationUnknownAtrial Fibrillation | Cardiac ArrhythmiaUnited States
-
China Rehabilitation Research CenterCapital Medical University; Ministry of Finance, ChinaCompleted